Skip to main content
. 2022 May 9;2022(5):CD012809. doi: 10.1002/14651858.CD012809.pub2

2. Summary of investigations for heterogeneity.

Covariate Subgroup Number of studies Number of participants Number of cases Sensitivity Specificity
Overall   17 3656 1342 Median (range): 87% (40% to 98%) Median (range): 86% (33% to 100%)
WHO Classification of PH Not Group 3 3 279 87 Median (range): 76% (75% to 87%) Median (range): 91% (91% to 95%)
Group 3 2 237 142 Median (range): 63% (40% to 85%) Median (range): 77% (66% to 88%)
Not reported 12 3141 1113 Median (range): 92% (67% to 98%) Median (range): 85% (33% to 100%)
The methods used to estimating RAP Using the diameter of IVC 9 3057 967 Median (range): 92% (76% to 98%) Median (range): 89% (55% to 100%)
Not using the diameter of IVC 2 114 70 Median (range): 81% (75% to 87%) Median (range): 91% (91% to 91%)
Not reported 6 485 305 Median (range): 83% (40% to 95%) Median (range): 83% (33% to 88%)
Threshold groups < 36 mmHg 8 1061 711 Pooled sensitivity (95% CI):
89% (79% to 94%)
Pooled specificity (95% CI):
83% (70% to 91%)
≥ 36 mmHg and < 40 mmHg 4 2034 328 Pooled sensitivity* (95% CI):
85% (57% to 96%)
Pooled specificity* (95% CI):
80% (76% to 84%)
≥ 40 mmHg 5 561 303 Pooled sensitivity* (95% CI):
88% (83% to 92%)
Pooled specificity* (95% CI):
89% (85% to 93%)

* Pooled sensitivity and specificity estimated by the bivariate random effects model

Abbreviations:
CI: confidence interval
IVC: inferior vena cava
PH: pulmonary hypertension
RAP: right atrial pressure
WHO: World Health Organization